MERUS LABS INTERNATIONAL Aktie

0,00 0,0000%

Zu Ihrem Onlinebroker

kaufen verkaufen

MERUS LABS INTERNATIONAL Aktienkurs : 01.01. ( 15 Min. verzögert)
0,0000000 Letzter Kurs	0,00% Veränderung	0,0000000 Vortag	0,0000000 Eröffnungskurs

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
0,0000000 - 0,0000000 Tag	0,0000000 - 0,0000000 52 Wochen	0 Tag	0 Ø 52 Wochen	0,0000000 0 Stücke	0,0000000 0 Stücke

MERUS LABS INTERNATIONAL Akti…

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

16.05.

Cornerstone Therapeutics Reports First Quarter 2012 Financial Results

Consistent with Cornerstone's strategy, in March 2012 the Company sold the anti-infective product lines, Factive ® and Spectracef ® , to Merus Labs International Inc. and Vansen Pharma Inc., respectively, in exchange for cash consideration and the ...
16.05.

Merus Labs International Inc. Announces Second Quarter Results for Fiscal 2012

TORONTO, ONTARIO, May 15, 2012 (MARKETWIRE via COMTEX) -- Merus Labs International Inc. ("Merus" or the "Company") (TOR:CA:MSL) (NASDAQ:MSLI) is pleased to announce today its financial results for the second quarter of...

15.05.

Cornerstone Therapeutics Reports First Quarter 2012 Financial Results

Consistent with Cornerstone's strategy, in March 2012 the Company sold the anti-infective product lines, Factive(R) and Spectracef(R), to Merus Labs International Inc. and Vansen Pharma Inc., respectively, in exchange for cash consideration and the ...
09.05.

Nasdaq stocks posting largest volume increases

Merus Labs International Inc. : Approximately 218100 shares changed hands, a 2962.6 percent increase over its 65-day average volume. The shares fell $.13 or 7.6 percent to $1.58. Sapiens Internationa…
04.05.

Merus Labs to Close $10 Million Bough Deal Financing

Merus Labs International Inc. (TSX: MSL; NASDAQ: MSLI] has engaged a syndicate of underwriters co-led by Canaccord Genuity Corp. and Clarus Securities Inc. for a bought deal short form prospectus off…